William Hearl is founder and chief executive officer of Immunomic Therapeutics. (Marvin Joseph/The Washington Post)

“My perspective on it has always been that if we figure out a way to cure a cancer, any cancer, we don’t have to worry about finding the money. The money will find us. The issue for us is making sure that we’re pursuing sound scientific principles that don’t endanger patients, and looking for ways to make people’s lives better.”

William Hearl, founder and chief executive, Immunomic Therapeutics

This excerpt was from the December 6 Washington Post Live program Chasing Cancer. Video of the discussions can be see at Wapo.st/chasingcancer.